VUELO GROUP LIMITED
Company number 14958596 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
VUELO GROUP LIMITED - Analysis Report
Company Number: 14958596
Analysis Date: 2025-07-20 17:27 UTC
Financial Health Assessment for VUELO GROUP LIMITED
1. Financial Health Score: B
Explanation:
VUELO GROUP LIMITED demonstrates a solid initial financial foundation typical of a newly incorporated company. The company shows strong liquidity with a healthy cash balance and minimal short-term liabilities, indicating good "circulatory" health in terms of cash flow management. However, the presence of an accumulated loss in the profit and loss reserve signals some "symptoms" of early-stage investment or operational costs exceeding revenues, common in startup phases, which merit close monitoring.
2. Key Vital Signs
| Vital Sign | Value | Interpretation |
|---|---|---|
| Current Assets | £443,610 | High level of short-term resources to cover immediate needs; "healthy cash flow." |
| Cash on Hand | £300,666 | Strong liquidity cushion, indicating good cash availability. |
| Current Liabilities | £2,863 | Very low short-term debt; minimal pressure on immediate obligations. |
| Net Current Assets | £440,747 | Excellent working capital; company can comfortably meet short-term liabilities. |
| Net Assets (Equity) | £468,870 | Positive net worth signals financial stability at balance sheet level. |
| Shareholders’ Funds | £500,048 | Equity capital exceeds net assets, reflecting initial investments and share premium. |
| Profit and Loss Reserve | -£31,189 | Accumulated losses; suggests early operational costs or investment phase losses. |
| Intangible Assets | £28,123 | Investment in non-physical assets like intellectual property or software, typical for holding companies. |
| Debtors | £142,944 | Funds owed to the company, largely from related entities, indicating intra-group transactions. |
3. Diagnosis
The company is in the early "growth and development" stage. The balance sheet shows a robust liquidity position with significant cash and receivables far exceeding liabilities, akin to a "healthy pulse" of incoming and available funds. The minimal current liabilities reduce short-term financial stress, reflecting prudent debt management.
However, the presence of a negative profit and loss reserve (accumulated losses) signals that the company is yet to generate net profits; this is common for new ventures investing in setup costs or intangible assets. The intangible assets and share premium point to capital raised for strategic development rather than operational cash flow.
The company's going concern statement highlights reliance on investor support, a typical "life support" for startups. The director appointments and control structure show active governance, but the recent name change and director turnover (with one resignation) may suggest some organizational adjustments.
In summary, the company exhibits "healthy vital signs" with strong liquidity and equity but "symptoms" of early-stage financial strain from operational losses and investment outlays. The underlying business health appears stable but dependent on continued investor backing and effective management of expenses to move towards profitability.
4. Recommendations
- Monitor Cash Flow Closely: Maintain the strong liquidity position by controlling expenditures, especially intangible asset investments, to avoid cash depletion.
- Focus on Profitability: Develop a clear revenue generation strategy to reverse the negative profit and loss reserve, moving from investment phase to income generation.
- Manage Debtor Risk: Ensure timely collection of debts, particularly intra-group receivables, to maintain working capital health.
- Strengthen Governance: Stabilize the board and director roles to ensure consistent strategic oversight and operational guidance.
- Plan for Future Funding: Given reliance on investor support, prepare for future capital raises or loans to support growth without jeopardizing solvency.
- Regular Financial Reviews: Conduct periodic detailed financial health checks to detect "symptoms" of distress early, especially as operational scale increases.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.